WEIGAO GROUP repurchases 0.50 million H-shares for HK$1.90 million; treasury stock rises to 48.44 million

Bulletin Express04-01

Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a share buyback executed on 1 April 2026, repurchasing 0.50 million H-shares on the Hong Kong Stock Exchange at prices between HK$3.75 and HK$3.84 per share. The transaction totalled HK$1.90 million, translating into a volume-weighted average of HK$3.804 per share.

Following the buyback: • Issued shares (excluding treasury shares) decreased by 0.011 % to 4.47 billion. • Treasury shares increased to 48.44 million. • Total issued shares remained unchanged at 4.52 billion, as the repurchased shares are being held as treasury stock and have not been cancelled.

The repurchase forms part of the mandate approved on 27 May 2025, which authorises WEIGAO GROUP to buy back up to 451.56 million shares. Cumulative repurchases under this mandate have reached 41.80 million shares, equivalent to 9.26 % of the issued share capital on the mandate’s approval date. A moratorium on new share issues or treasury-share disposals is in place until 2 May 2026, in line with Hong Kong listing rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment